Eiger BioPharmaceuticals EV - Enterprise Value 2011-2026 | EIGR

Annual EV - Enterprise Value Eiger BioPharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
31 M	42 M	202 M	307 M	288 M	162 M	67.3 M	62.5 M	24.3 M	416 M	156 M	-1.77 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
416 M	-1.77 M	146 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
Amphastar Pharmaceuticals AMPH	1.92 B	$ 21.65	-	$ 1.01 B	USA
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Ampio Pharmaceuticals AMPE	-1.05 M	-	-11.43 %	$ 502 K	USA
Midatech Pharma plc MTP	-1.76 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Applied Therapeutics APLT	563 M	-	-	$ 8.42 M	USA
Aptorum Group Limited APM	9.45 M	$ 0.9	-0.18 %	$ 6.62 M	China
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	3.33 B	$ 22.3	-	$ 3.7 B	USA
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
Cara Therapeutics CARA	-9.61 M	-	-3.03 %	$ 260 M	USA
CASI Pharmaceuticals CASI	1.08 B	-	-	$ 35.4 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Fennec Pharmaceuticals FENC	167 M	$ 6.85	-	$ 196 M	USA
ChromaDex Corporation CDXC	-34.9 M	-	-0.88 %	$ 598 M	USA
Aeterna Zentaris AEZS	10.3 M	-	5.93 %	$ 314 M	Canada
Galectin Therapeutics GALT	306 M	$ 2.37	-	$ 151 M	USA
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Greenwich LifeSciences GLSI	112 M	$ 23.99	-	$ 312 M	USA
Aridis Pharmaceuticals ARDS	38.2 M	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	-4.91 B	$ 102.06	-	$ 27.2 B	Germany
Checkpoint Therapeutics CKPT	174 M	-	-	$ 169 M	USA
Avenue Therapeutics ATXI	-1.76 M	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Heron Therapeutics HRTX	411 M	$ 1.19	-	$ 198 M	USA
Aquestive Therapeutics AQST	540 M	$ 4.1	-	$ 438 M	USA
Arcutis Biotherapeutics ARQT	3.64 B	$ 23.42	-	$ 2.98 B	USA
ImmuCell Corporation ICCC	69.7 M	$ 8.25	-	$ 74.5 M	USA
Autolus Therapeutics plc AUTL	629 M	$ 1.42	-	$ 378 M	Britain
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	59.6 B	-	-	$ 96.9 B	Britain
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
Inventiva S.A. IVA	129 M	$ 5.13	-	$ 138 M	France
Can-Fite BioPharma Ltd. CANF	647 M	$ 2.92	-	$ 4.81 M	Israel
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
Kamada Ltd. KMDA	252 M	$ 8.2	-	$ 260 M	Israel